Bellicum Pharmaceuticals, Inc.
[NASDAQ: BLCM]; based in Houston, Texas; incorporated in Delaware
Lead Plaintiff Deadline: 04/09/2018
Case #: 18-cv-408
Court: USDC, Southern District of Texas
Notes: Lead or Derivative Plaintiffs; Class Period is 5/8/2017 to 1/40/2018
